Clinical immunity to malaria

Current Molecular Medicine
Louis Schofield, Ivo Mueller

Abstract

Under appropriate conditions of transmission intensity, functional immunity to malaria appears to be acquired in distinct stages. The first phase reduces the likelihood of severe or fatal disease; the second phase limits the clinical impact of 'mild' malaria; and the third provides partial but incomplete protection against pathogen burden. These findings suggest clinical immunity to mortality and morbidity is acquired earlier, with greater ease, and via distinct mechanisms as compared to anti-parasite immunity, which is more difficult to achieve, takes longer and is only ever partially efficacious. The implications of this view are significant in that current vaccination strategies aim predominantly to achieve anti-parasite immunity, although imparting clinical immunity is the public health objective. Despite enormous relevance for global public health, the mechanisms governing these processes remain obscure. Four candidate mechanisms might mediate clinical immunity, namely immunity to cytoadherence determinants, tolerance to toxins, acquired immunity to toxins, and immunoregulation. This review addresses the targets and determinants of clinical immunity, and considers the implications for vaccine development.

Citations

Nov 30, 2006·Wiener klinische Wochenschrift·Nicole WesterfeldRinaldo Zurbriggen
Jun 5, 2008·The Journal of Infectious Diseases·Tamara D ClarkGrant Dorsey
Oct 25, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marthe C D'OmbrainLouis Schofield
Jan 13, 2009·Clinical Microbiology Reviews·Denise L DoolanJ Kevin Baird
Nov 13, 2008·Infection and Immunity·Julia K NunesDyann F Wirth
Sep 13, 2013·BMC Infectious Diseases·Lindsay T Keegan, Jonathan Dushoff
Dec 29, 2012·PLoS Neglected Tropical Diseases·Laurens ManningTimothy M E Davis
Jan 21, 2011·PloS One·Odile Ouwe-Missi-Oukem-BoyerSylvie Bisser
May 5, 2012·PloS One·Sulabha PathakShobhona Sharma
May 21, 2010·PLoS Pathogens·Stephanie G ValderramosDavid A Fidock
Nov 4, 2011·The American Journal of Tropical Medicine and Hygiene·Michael MakangaPhilip J Rosenthal
Mar 25, 2014·Annual Review of Immunology·Peter D CromptonSusan K Pierce
Jan 10, 2014·Memórias do Instituto Oswaldo Cruz·Gauri Awasthi, Aparup Das
Feb 12, 2013·International Journal of Antimicrobial Agents·E Y Klein
Jul 26, 2011·Acta Tropica·Sócrates HerreraMyriam Arévalo-Herrera
Jan 9, 2010·Trends in Immunology·Olivia C FinneyMichael Walther
Aug 22, 2007·Mathematical Biosciences·David Gurarie, F Ellis McKenzie
Oct 19, 2006·Vaccine·Marc P GirardMarie Paule Kieny
Dec 3, 2014·Frontiers in Microbiology·Wan Ni ChiaLaurent Rénia
Sep 8, 2010·International Journal for Parasitology·Denise L Doolan
Mar 29, 2014·Memórias do Instituto Oswaldo Cruz·Rodrigo Nunes Rodrigues-da-SilvaJoseli de Oliveira-Ferreira
Aug 12, 2015·The American Journal of Tropical Medicine and Hygiene·Christopher L KingBryan Greenhouse
Jul 16, 2014·Molecular & Cellular Proteomics : MCP·Olivia C FinneyRuobing Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Related Papers

Parasite Immunology
Kevin Marsh, S Kinyanjui
Parasite Immunology
Eleanor M RileyLouis Schofield
Immunological Reviews
Siske S Struik, Eleanor M Riley
Nature Reviews. Immunology
Louis Schofield, G E Grau
© 2021 Meta ULC. All rights reserved